Baker IDI Heart and Diabetes Institute, Melbourne, Australia Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia
Baker IDI Heart and Diabetes Institute, Melbourne, Australia Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia.
Diabetes Care. 2015 Jul;38(7):1274-80. doi: 10.2337/dc14-2820. Epub 2015 Jun 12.
To investigate infection-related mortality in individuals with type 1 and type 2 diabetes.
A total of 1,108,982 individuals with diabetes who were registered with the Australian Diabetes register between 2000 and 2010 were linked to the National Death Index. Mortality outcomes were defined as infection-related(A-B) death (ICD codes A99-B99), pneumonia (J12-J189), septicemia (A40 and A41), and osteomyelitis (M86).
During a median follow-up of 6.7 years, there were 2,891, 2,158, 1,248, and 147 deaths from infection-related(A-B) causes, pneumonia, septicemia, or osteomyelitis, respectively. Crude mortality rates from infections(A-B) were 0.147 and 0.431 per 1,000 person-years in type 1 and type 2 diabetes, respectively. Standardized mortality ratios (SMRs) were higher in type 1 and type 2 diabetes for all outcomes after adjustment for age and sex. For infection-related(A-B) mortality, SMRs were 4.42 (95% CI 3.68-5.34) and 1.47 (1.42-1.53) for type 1 and type 2 diabetes (P < 0.001), respectively. For pneumonia in type 1 diabetes, SMRs were approximately 5 and 6 in males and females, respectively, while the excess risk was ∼20% for type 2 (both sexes). For septicemia, SMRs were approximately 10 and 2 for type 1 and type 2 diabetes, respectively, and similar by sex. For osteomyelitis in type 1 diabetes, SMRs were 16 and 58 in males and females, respectively, and ∼3 for type 2 diabetes (both sexes).
Although death owing to infection is rare, we confirm that patients with diabetes have an increased mortality from a range of infections, compared with the general population, and that the increased risk appears to be greater for type 1 than type 2 diabetes.
研究 1 型和 2 型糖尿病患者的感染相关死亡率。
本研究共纳入 2000 年至 2010 年间在澳大利亚糖尿病登记处登记的 1108982 名糖尿病患者,并将其与国家死亡索引相关联。将死亡率定义为感染相关(A-B)死亡(ICD 编码 A99-B99)、肺炎(J12-J189)、败血症(A40 和 A41)和骨髓炎(M86)。
在中位随访 6.7 年期间,分别有 2891、2158、1248 和 147 人因感染相关(A-B)、肺炎、败血症或骨髓炎而死亡。1 型和 2 型糖尿病患者的感染(A-B)粗死亡率分别为 0.147 和 0.431/1000 人年。校正年龄和性别后,1 型和 2 型糖尿病患者的所有结局的标准化死亡率比(SMR)均较高。对于感染相关(A-B)死亡率,1 型和 2 型糖尿病的 SMR 分别为 4.42(95%CI 3.68-5.34)和 1.47(1.42-1.53)(P<0.001)。1 型糖尿病患者的肺炎,男性和女性的 SMR 分别约为 5 和 6,而 2 型糖尿病患者的风险增加约 20%(男女均有)。对于败血症,1 型和 2 型糖尿病的 SMR 分别约为 10 和 2,且性别间无差异。1 型糖尿病患者的骨髓炎,男性和女性的 SMR 分别为 16 和 58,而 2 型糖尿病患者的 SMR 约为 3(男女均有)。
尽管感染导致的死亡很少见,但我们证实与一般人群相比,糖尿病患者死于各种感染的死亡率增加,且这种风险似乎在 1 型糖尿病中比 2 型糖尿病更高。